How Buying NuScale Power (SMR) Stock Today Could 10X Your Net Worth

NuScale Power, a developer of small modular nuclear reactors that went public via SPAC in May 2022, has seen its stock fall from a $53.43 peak to about $19 and currently carries a ~$5.5 billion market cap despite NRC Standard Design Approvals for 50 MWe and 77 MWe units. Analysts model very modest near-term revenue—$40 million and a $360 million net loss in 2025—rising to $293 million revenue and a $67 million net loss by 2027, with upside dependent on a Romania FID, progress on a TVA pipeline not expected to be operational until 2032, and new hyperscale data-center orders. The piece outlines a high‑risk/high‑return scenario in which a 40% top‑line CAGR through 2035 could boost revenue to $1.5 billion and imply a potential 10x market‑cap outcome if valuation expands, but stresses material execution and funding risks given past project cancellations and a 40% workforce reduction.

Analysis

Market structure: NuScale (SMR) is a potential winner if it converts SDAs into repeatable supply contracts — Fluor (FLR) and fabricators win as subcontractors, hyperscale data centers and TVA-like utilities gain optionality for on-site baseload. Competitive dynamics favor NuScale’s regulatory moat (only SDA holder) but pricing power will be constrained by EPC competition and project finance cost pressure; at $5.5bn market cap trading ~19x 2027 sales ($293m est.) the stock prices a successful commercialization path. Supply/demand signals point to an early-stage market: Research & Markets’ 42% CAGR to 2035 implies demand expansion, but near-term supply is limited by fabrication capacity and skilled labor with meaningful uranium and construction commodity upside if deployments accelerate.

Risk assessment: Tail risks include regulatory reversals, FEED-to-FID failures (Romania decision this year) and multi-year construction cost overruns (Idaho precedent), each capable of wiping >50% of forecast revenues through 2027. Time horizons matter: expect acute volatility in days-weeks around Romania FID, TVA permitting milestones through 2027, and fundamental realization (or failure) in 2027–2035 as modules are built; hidden dependencies include Fluor execution, DOE loan programs, and domestic factory scale-up. Key catalysts that could re-rate SMR: Romania FID (next 6–12 months), TVA contract FID/PPAs by 2032, and 1–2 hyperscaler PPAs within 24 months.

Trade implications: Construct a bifurcated trade: establish a small asymmetric long in SMR via LEAP calls (buy Jan 2028 25C, size 1–2% portfolio) funded by selling short-dated calls or buying a 2026 put (downside hedge to $12). Pair trade: long FLR (0.5–1% of portfolio) to capture steady EPC cashflows and short SMR equity or buy SMR 2026 15P if Romania/TVA milestones miss — expect >30% downside in that scenario. Rotate 1–3% from speculative green/tech SPACs into uranium equities (URA or large producers) and engineering names; exit longs if SMR reports missed FEED revenue >20% below consensus or if SMR market cap >$20bn without commensurate booked orders.

Contrarian angles: Consensus underweights the regulatory moat — SDAs lower licensing risk versus peers, which could compress time-to-revenue if scale manufacturing is solved; conversely the market may be underestimating hyperscalers’ willingness to pay for guaranteed low-carbon baseload near AI hubs. The 60% decline may be overdone if Romania FID and initial TVA milestones materialize (binary upside >3x from current in that path), but equally underpriced for execution failure. Historical parallels: modular infra rollouts (e.g., offshore wind manufacturing scale) show large upfront capital and long lead-times; unintended consequence of rapid SMR deployment would be sharp uranium and skilled labor inflation that increases project costs and shortens margins for first movers.

Key Decisions for Investors

• Establish a tactical 1–2% portfolio position in SMR via LEAP calls (Jan 2028 25C) to capture asymmetric upside if Romania FID occurs within 12 months or TVA advances; size small due to binary execution risk and hedge with purchase of SMR 2026 12–15P (protects to ~40% downside).
• Allocate 0.5–1% long to Fluor (FLR) equity to play steady EPC revenues from SMR buildouts and sell a 6–12 month covered call (10–20% OTM) to improve yield; reduce or exit if FLR guidance cuts >15% or SMR cancels major subcontracts.
• Short SMR outright (or buy 2026 15P) sized 1% if Romania FID is delayed beyond 12 months or if FEED revenue for 2025 misses consensus by >20%; target take-profit at 30–50% decline in SMR share price.
• Rotate 1–3% from speculative SPAC/clean-tech holdings into uranium exposure (physical ETF URA or 2–4 large producers) over 3–9 months to hedge upside in reactor rollouts, and increase exposure if multiple PPAs from hyperscalers are announced within 24 months.
• Monitor three specific triggers in next 30–365 days before scaling positions: Romania final investment decision (within 12 months), TVA PPA/FID milestones (by 2032 timeline updates), and any DOE/DOE loan guarantee announcement (within 6–12 months); act (scale up/down by 1–3%) upon each binary outcome.